Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CG ONCOLOGY, INC.”

5 pharma patents match "CG ONCOLOGY, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "CG ONCOLOGY, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “CG ONCOLOGY, INC.” · 30,257 patents in full index Clear search

  1. US 12370229

    Methods of treating bladder cancer

    CG ONCOLOGY, INC. · Granted Jul 29, 2025 · Expires Jul 24, 2045

    granted

  2. US 12090183

    Methods of treating solid or lymphatic tumors by combination therapy

    CG ONCOLOGY, INC. · Granted Sep 17, 2024 · Expires Sep 12, 2044

    granted

  3. US 11596660

    Methods of treating bladder cancer

    CG ONCOLOGY, INC. · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  4. US 11497781

    Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor

    CG ONCOLOGY, INC. · Granted Nov 15, 2022 · Expires Nov 10, 2042

    granted

  5. US 11338003

    Methods of treating bladder cancer with an oncolytic virus

    CG ONCOLOGY, INC. · Granted May 24, 2022 · Expires May 19, 2042

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.